NCT02228382 2021-12-30Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase InhibitorsPfizerPhase 4 Terminated163 enrolled 27 charts
NCT01663766 2021-08-19Phase I Study of Milatuzumab for Graft Versus Host DiseaseGilead SciencesPhase 1 Terminated12 enrolled